Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Genetics of Atherosclerosis in Mexican Americans

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00005462
First received: May 25, 2000
Last updated: July 11, 2016
Last verified: July 2008
  Purpose
To identify individual genes that contribute to variation in susceptibility to coronary heart disease (CHD) in Mexican Americans. The program project grant supports the San Antonio Family Heart Study, the first comprehensive genetic epidemiological study of atherosclerosis and its correlates in Mexican Americans.

Condition
Cardiovascular Diseases
Coronary Disease
Obesity
Atherosclerosis
Diabetes Mellitus, Non-insulin Dependent
Diabetes Mellitus

Study Type: Observational

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: September 1991
Study Completion Date: May 2008
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005462

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
OverallOfficial: Jean MacCluer Southwest Foundation for Biomedical Research
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00005462     History of Changes
Other Study ID Numbers: 4906  P01HL045522-14 
Study First Received: May 25, 2000
Last Updated: July 11, 2016
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Diabetes Mellitus
Cardiovascular Diseases
Atherosclerosis
Coronary Disease
Coronary Artery Disease
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Myocardial Ischemia
Heart Diseases

ClinicalTrials.gov processed this record on December 09, 2016